T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Euronet Worldwide
EEFT
$2.66B
| $25.5M | 0.01% |
344,690
-2,490
| -0.7% | -$176K |
|
|
DST
1002
DELISTED
DST Systems Inc.
DST
| $25.5M | 0.01% |
452,472
+28,810
| +7% | +$1.53M |
|
|
AAT
1003
American Assets Trust
AAT
$1.39B
| $25.4M | 0.01% |
635,110
+240
| +0% | +$8.96K |
|
|
SRCL
1004
DELISTED
Stericycle Inc
SRCL
| $25.3M | 0.01% |
200,805
+5,800
| +3% | +$676K |
|
1005
Seres Therapeutics
MCRB
$47.4M
| $25.3M | 0.01% |
47,542
-541
| -1% | -$282K |
|
1006
PDF Solutions
PDFS
$2.19B
| $25.1M | 0.01% |
1,874,961
-13,220
| -0.7% | -$145K |
|
|
FDC
1007
DELISTED
First Data Corporation
FDC
| $24.9M | 0.01% |
1,920,632
-4,759,474
| -71% | -$61.2M |
|
|
CTRA
1008
DELISTED
Coterra Energy
CTRA
| $24.8M | 0.01% |
1,089,990
+79,630
| +8% | +$1.6M |
|
1009
CTS Corp
CTS
$1.82B
| $24.7M | 0.01% |
1,567,610
-12,380
| -0.8% | -$185K |
|
|
UAM
1010
DELISTED
Universal American Corp
UAM
| $24.7M | 0.01% |
3,453,159
-109,991
| -3% | -$714K |
|
|
ANTX
1011
DELISTED
Anthem, Inc.
ANTX
| $24.6M | 0.01% |
534,800
-5,200
| -1% | -$234K |
|
|
WBMD
1012
DELISTED
WebMD Health Corp.
WBMD
| $24.6M | 0.01% |
393,210
+5,540
| +1% | +$297K |
|
1013
World Kinect Corp
WKC
$1.89B
| $24.6M | 0.01% |
505,919
+34
| +0% | +$1.46K |
|
1014
Simmons First National
SFNC
$3.45B
| $24.5M | 0.01% |
1,089,360
-740
| -0.1% | -$16.3K |
|
1015
DNOW Inc
DNOW
$3.04B
| $24.5M | 0.01% |
+1,382,659
| New | +$21.3M |
|
|
AGFS
1016
DELISTED
AgroFresh Solutions Inc
AGFS
| $24.3M | 0.01% |
3,794,359
+1,991,259
| +110% | +$10.8M |
|
|
INVN
1017
DELISTED
Invensense Inc
INVN
| $24.2M | 0.01% |
2,885,250
-11,120
| -0.4% | -$88.3K |
|
|
P
1018
DELISTED
Pandora Media Inc
P
| $24.2M | 0.01% |
2,707,863
-93,215
| -3% | -$915K |
|
1019
Nordson
NDSN
$17.3B
| $24.1M | 0.01% |
316,837
-214,320
| -40% | -$14.1M |
|
1020
Copart
CPRT
$27.2B
| $24M | 0.01% |
4,699,712
+3,100,960
| +194% | +$14.3M |
|
1021
Marriott Vacations Worldwide
VAC
$4.1B
| $23.8M | 0.01% |
352,728
-6,010
| -2% | -$340K |
|
1022
Regions Financial
RF
$26.9B
| $23.6M | 0.01% |
3,008,260
+644,085
| +27% | +$5.18M |
|
|
FARO
1023
DELISTED
Faro Technologies
FARO
| $23.6M | 0.01% |
732,680
-2,750
| -0.4% | -$76.9K |
|
1024
Atlantic Union Bankshares
AUB
$6.09B
| $23.5M | 0.01% |
953,630
+9,970
| +1% | +$230K |
|
1025
MGIC Investment
MTG
$6.29B
| $23.5M | 0.01% |
3,061,449
-142,672
| -4% | -$1.02M |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.